Venture Funding and the NIH SBIR Program (2009)
Chapter: Appendix C: NIH List of Firms Excluded on the Grounds of Venture Capital Ownership
Appendix C
NIH List of Firms Excluded on the Grounds of Venture Capital Ownership*
FIRM NAME
Altus Biologics, Inc.
Applied Genetic Technologies Corp.
Arginox Pharmaceuticals
Argolyn Bioscience, Inc.
Arizeke Pharmaceuticals
Ascenta Therapeutics, Inc.
Aspect Medical Systems, Inc.
Biospect Inc./Predicant Biosciences
BrainCells, Inc.
Calypso Medical Technologies, Inc.
Cell Biosciences
Cengent Therapeutics, Inc.
CEPTYR, Inc.
Cerus Corporation
Chlorogen
CUMBRE, Inc.
Diversa Corp.
Encysive Pharmaceuticals
FivePrime Therapeutics
GlycoFi, Inc.
Gryphon Therapeutics, Inc.
Handylab Inc.
IDM Pharma, Inc.
Infigen, Inc.
Inotek Pharmaceuticals
Lincoln Technologies
Macrogenics, Inc.
MEMX
Metabolon, Inc.
MicroOptical Corporation
MicroOptical Engineering Corporation
Myomatrix Therapeutics
NanoMix, Inc.
NanoString Technologies, Inc.
Natus Medical (BioLogics)
Nephros Therapeutics, Inc.
Neurogenetics, Inc.
Norak Biosciences, Inc.
Northwest Medical Physics Equipment
Paratek Pharmaceuticals
Peptx, Inc.
Phenomix Corp.
PTC Therapeutics, Inc.
Saegis Pharmaceuticals Inc.
Sentrx Surgical/Carbylan Biosurgery
Sirtris Pharmaceuticals
Threshold Pharmaceuticals, Inc.
Transave, Inc.
Traxtal, Inc.
Trellis Bioscience
Tularik, Inc.
Vion Pharmaceuticals, Inc.
Virxsys Corp.
VisEn Medical, Inc.
Yasoo Health, Inc.
